Senators Warn Equifax Against Profiteering from Medicaid Changes
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 03 2026
0mins
Should l Buy EFX?
Source: seekingalpha
- Stock Price Drop: Equifax (EFX) shares fell 12% in midday trading on Tuesday following reports of senators warning the company against potential profiteering, indicating market concerns over its profitability amid new Medicaid work requirements.
- Regulatory Warning: Senators Elizabeth Warren, Ron Wyden, and Bernie Sanders sent a letter to Equifax's CEO, cautioning that the company might exploit its dominant market position to raise prices and increase profits, exacerbating competitive inequalities.
- New Platform Launch: Equifax is proactively developing a platform called 'TotalVerify' aimed at assisting state governments in meeting the 2027 Medicaid work requirements, which could further solidify its market position and enhance profitability.
- Analyst Outlook: Despite the senators' warnings, UBS analyst Kevin McVeigh believes that the 'TotalVerify' platform will aid states in compliance, potentially benefiting Equifax's stock, reflecting a divergent view on its long-term growth prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EFX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EFX
Wall Street analysts forecast EFX stock price to rise
13 Analyst Rating
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 188.180
Low
234.00
Averages
262.42
High
295.00
Current: 188.180
Low
234.00
Averages
262.42
High
295.00
About EFX
Equifax Inc. is a global data, analytics, and technology company. The Company is engaged in helping financial institutions, companies, employers, and government agencies make critical decisions. The Company’s Workforce Solutions segment provides services enabling customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure and sanctions of people in the United States. The Company’s U.S. Information Solutions (USIS) segment provides consumer and commercial information solutions to businesses in the United States, including online information, decisioning technology solutions, identity management services, analytical services, e-commerce fraud and charge back protection services, portfolio management services, mortgage information and marketing services. The Company’s International segment provides products and services similar to those available in the USIS segment but with variations by geographic region.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Equifax (EFX.US) Executive Plans to Sell $7.4 Million in Common Stock via Form 144
Stock Sale Announcement: Equifax officer Mark Wintend plans to sell 37,791 shares of the company's common stock.
Market Value: The total market value of the shares being sold is approximately $7.4 million.
See More
Equifax Reports Strong Q4 Earnings, Beats Estimates
- Strong Earnings Report: Equifax reported an adjusted EPS of $2.09 for Q4, surpassing market expectations of $2.05, indicating robust profitability that boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $1.551 billion, exceeding the anticipated $1.527 billion, demonstrating Equifax's sustained competitiveness in the market, which contributed to its stock price increase.
- Future Outlook: Equifax projects FY2026 adjusted EPS between $8.30 and $8.70, slightly below the market estimate of $8.74, while forecasting sales of $6.660 billion to $6.780 billion, indicating stable growth potential.
- Analyst Rating Adjustments: Following the earnings announcement, Needham's Kyle Peterson maintained a Buy rating but lowered the price target from $295 to $265, while Morgan Stanley's Toni Kaplan kept an Overweight rating, reducing the target from $269 to $244, reflecting a cautious market sentiment regarding Equifax's future performance.
See More
Texas Instruments Acquires Silicon Labs in $7.5B Deal
- Acquisition Agreement: Texas Instruments is set to acquire Silicon Labs for $231 per share in an all-cash transaction valued at $7.5 billion, which not only boosts Silicon Labs' market valuation but also enhances Texas Instruments' competitive edge in the semiconductor sector.
- Positive Market Reaction: Following the acquisition announcement, Silicon Labs' stock surged by 49%, indicating strong investor confidence in the deal and reflecting optimistic expectations for consolidation within the semiconductor industry.
- Strong Earnings Performance: Silicon Labs reported an adjusted EPS of 56 cents for Q4, slightly above the consensus estimate of 55 cents, demonstrating stable financial performance that enhances the attractiveness of the acquisition.
- Industry Consolidation Trend: This acquisition represents a strategic move for Texas Instruments to expand its product line and signifies an acceleration in semiconductor industry consolidation, potentially triggering more similar deals that could reshape the market landscape.
See More
Equifax (EFX) Q4 2025 Earnings Call Transcript
See More
Equifax Issues Financial Guidance for 2026
- Q1 2026 Expectations: Equifax anticipates adjusted earnings per share between $1.63 and $1.73 for Q1 2026, with revenue projected at $1.597 billion to $1.627 billion, indicating a cautiously optimistic outlook for the market.
- Annual Financial Outlook: The company projects adjusted earnings per share of $8.30 to $8.70 for fiscal 2026, with revenue expected between $6.660 billion and $6.780 billion, reflecting a positive outlook for future market conditions.
- Comparison to 2025: In Q1 2025, Equifax recorded adjusted earnings of $1.53 per share and revenue of $1.442 billion, demonstrating ongoing growth in both revenue and profitability.
- Market Reaction: EFX shares rose by 0.02% to $175 in pre-market trading on the New York Stock Exchange, indicating investor optimism regarding the company's future prospects.
See More
Equifax Exceeds Q4 Earnings, Raises Annual Profit Forecast
- Upgraded Profit Forecast: Equifax anticipates annual revenue between $6.66 billion and $6.78 billion for 2023, surpassing Wall Street's expectation of $6.59 billion, indicating robust performance amid high interest rates.
- Mortgage Segment Growth: The company reported a 20% increase in U.S. mortgage revenue for Q4, reflecting a rebound in loan demand supported by a resilient labor market and economy, which boosts the need for credit scores and risk assessments.
- Competitive Strategy: Equifax plans to expand its VantageScore mortgage credit score offerings to counter FICO's strategy of selling credit scores directly to lenders, aiming to enhance market share and achieve margin expansion.
- Quarterly Performance Exceeds Expectations: The company posted an adjusted earnings per share of $2.09 for Q4, beating analyst expectations of $2.05, with quarterly revenue reaching $1.55 billion, also above the projected $1.53 billion, showcasing strong financial performance.
See More
Equifax (EFX.US) Executive Plans to Sell $7.4 Million in Common Stock via Form 144
Stock Sale Announcement: Equifax officer Mark Wintend plans to sell 37,791 shares of the company's common stock.
Market Value: The total market value of the shares being sold is approximately $7.4 million.
See More
Equifax Reports Strong Q4 Earnings, Beats Estimates
- Strong Earnings Report: Equifax reported an adjusted EPS of $2.09 for Q4, surpassing market expectations of $2.05, indicating robust profitability that boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $1.551 billion, exceeding the anticipated $1.527 billion, demonstrating Equifax's sustained competitiveness in the market, which contributed to its stock price increase.
- Future Outlook: Equifax projects FY2026 adjusted EPS between $8.30 and $8.70, slightly below the market estimate of $8.74, while forecasting sales of $6.660 billion to $6.780 billion, indicating stable growth potential.
- Analyst Rating Adjustments: Following the earnings announcement, Needham's Kyle Peterson maintained a Buy rating but lowered the price target from $295 to $265, while Morgan Stanley's Toni Kaplan kept an Overweight rating, reducing the target from $269 to $244, reflecting a cautious market sentiment regarding Equifax's future performance.
See More
Texas Instruments Acquires Silicon Labs in $7.5B Deal
- Acquisition Agreement: Texas Instruments is set to acquire Silicon Labs for $231 per share in an all-cash transaction valued at $7.5 billion, which not only boosts Silicon Labs' market valuation but also enhances Texas Instruments' competitive edge in the semiconductor sector.
- Positive Market Reaction: Following the acquisition announcement, Silicon Labs' stock surged by 49%, indicating strong investor confidence in the deal and reflecting optimistic expectations for consolidation within the semiconductor industry.
- Strong Earnings Performance: Silicon Labs reported an adjusted EPS of 56 cents for Q4, slightly above the consensus estimate of 55 cents, demonstrating stable financial performance that enhances the attractiveness of the acquisition.
- Industry Consolidation Trend: This acquisition represents a strategic move for Texas Instruments to expand its product line and signifies an acceleration in semiconductor industry consolidation, potentially triggering more similar deals that could reshape the market landscape.
See More
Equifax (EFX) Q4 2025 Earnings Call Transcript
See More
Equifax Issues Financial Guidance for 2026
- Q1 2026 Expectations: Equifax anticipates adjusted earnings per share between $1.63 and $1.73 for Q1 2026, with revenue projected at $1.597 billion to $1.627 billion, indicating a cautiously optimistic outlook for the market.
- Annual Financial Outlook: The company projects adjusted earnings per share of $8.30 to $8.70 for fiscal 2026, with revenue expected between $6.660 billion and $6.780 billion, reflecting a positive outlook for future market conditions.
- Comparison to 2025: In Q1 2025, Equifax recorded adjusted earnings of $1.53 per share and revenue of $1.442 billion, demonstrating ongoing growth in both revenue and profitability.
- Market Reaction: EFX shares rose by 0.02% to $175 in pre-market trading on the New York Stock Exchange, indicating investor optimism regarding the company's future prospects.
See More
Equifax Exceeds Q4 Earnings, Raises Annual Profit Forecast
- Upgraded Profit Forecast: Equifax anticipates annual revenue between $6.66 billion and $6.78 billion for 2023, surpassing Wall Street's expectation of $6.59 billion, indicating robust performance amid high interest rates.
- Mortgage Segment Growth: The company reported a 20% increase in U.S. mortgage revenue for Q4, reflecting a rebound in loan demand supported by a resilient labor market and economy, which boosts the need for credit scores and risk assessments.
- Competitive Strategy: Equifax plans to expand its VantageScore mortgage credit score offerings to counter FICO's strategy of selling credit scores directly to lenders, aiming to enhance market share and achieve margin expansion.
- Quarterly Performance Exceeds Expectations: The company posted an adjusted earnings per share of $2.09 for Q4, beating analyst expectations of $2.05, with quarterly revenue reaching $1.55 billion, also above the projected $1.53 billion, showcasing strong financial performance.
See More
